Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumors
Syk抑制剂sovleplenib治疗复发或难治性成熟B细胞肿瘤的I期研究
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2022.282401
Song, Yuqin; Cao, Junning; Zhang, Qingyuan; Li, Caixia; Qiu, Lugui; Qi, Junyuan; Zhang, Huilai; Li, Wenyu; Liu, Lihong; Jing, Hongmei; Zhou, Keshu; Zhang, Weijing; Zhang, Liling; Li, Daqi; Zou, Liqun; Yang, Haiyan; Qian, Wenbin; Zhou, Hui; Hu, Jianda; Yin, Hongyan; Fu, Sisi; Fan, Songhua; Xu, Qian; Wang, Jian; Jia, Xiaoyun; Dai, Guangxiu; Su, Weiguo; Zhu, Jun